Newsadmin2019-05-15T18:58:21-04:00

News

Source: NASDAQ

EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences
Published on 2019-05-15
EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress
Published on 2019-05-08
EyePoint Pharmaceuticals Presents Positive YUTIQ™ 36-month Follow-up Phase 3 Data at the 2019 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Published on 2019-05-01
EyePoint Pharmaceuticals Announces First Quarter 2019 Financial Results Release Date and Conference Call Information
Published on 2019-04-23
EyePoint Pharmaceuticals to Present at Upcoming Medical Conferences
Published on 2019-04-16
EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences
Published on 2019-04-02
EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Published on 2019-03-28
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
Published on 2019-03-27
EyePoint Pharmaceuticals Reports Fiscal Period Ended December 31, 2018 Financial Results and Highlights Recent Clinical and Operational Developments
Published on 2019-03-14
EyePoint Pharmaceuticals Announces U.S. Commercial Launch of DEXYCU (dexamethasone intraocular suspension) 9%
Published on 2019-03-12